Literature DB >> 10203429

The epidemiology of nonsteroidal anti-inflammatory drugs.

J Tenenbaum1.   

Abstract

Nonsteroidal anti-inflammatory drug (NSAID) use has increased dramatically in the past two decades. A large proportion of the elderly population (more than 65 years of age) holds a current or recent NSAID prescription, accounting for approximately 90% of all NSAID prescriptions. Despite studies that advise finding alternatives for NSAIDs for the management of osteoarthritis, physicians often prescribe NSAIDs first for such common musculoskeletal conditions. Despite being identified as risk factors for gastrointestinal complications, the simultaneous use of two NSAIDs and the coadministration of NSAIDs with corticosteroids and with coumadin continue to occur. The point prevalence of NSAID-induced ulcers is 10% to 30%, and 15% to 35% of all peptic ulcer complications are caused by NSAIDs. The increased risk of gastrointestinal complications when NSAIDs are used is 3% to 5%. This risk increases with other identified risk factors (eg, older age, previous gastrointestinal history, comorbid diseases and poor health). Gastrointestinal causes of hospitalization (eg, gastrointestinal hemorrhage and perforation) and death have increased in parallel to increased NSAID use. 'Antiulcer' agents are prescribed twice as often in NSAID users, and the economic impact (eg, diagnostic tests and hospitalization) is that about one-third of the arthritis budget has been dedicated to deal with gastrointestinal side effects of NSAIDs. Misoprostol and omeprazole have been shown to be cytoprotective for the gastroduodenal mucosa when NSAIDs are used, and misoprostol has been shown to reduce the risk of gastroduodenal ulcer complications. Economic evaluations have suggested that these agents are a cost effective means of dealing with such NSAID-associated problems. Although no NSAID is totally safe, a number of studies have demonstrated that NSAIDs may be ranked according to relative gastrointestinal toxicity. The role of Helicobacter pylori in NSAID-associated problems remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203429     DOI: 10.1155/1999/361651

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  10 in total

1.  Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.

Authors:  V Bongard; S Ménard-Taché; H Bagheri; K Kabiri; M Lapeyre-Mestre; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

2.  The anti-inflammatory drug indomethacin alters nanoclustering in synthetic and cell plasma membranes.

Authors:  Yong Zhou; Sarah J Plowman; Lenard M Lichtenberger; John F Hancock
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

3.  Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.

Authors:  Ravinder Kodela; Mitali Chattopadhyay; Satindra Goswami; Zong Yuan Gan; Praveen P N Rao; Kamran V Nia; Carlos A Velázquez-Martínez; Khosrow Kashfi
Journal:  J Pharmacol Exp Ther       Date:  2013-01-24       Impact factor: 4.030

4.  A sulfated-polysaccharide fraction from seaweed Gracilaria birdiae prevents naproxen-induced gastrointestinal damage in rats.

Authors:  Renan O Silva; Ana Paula M Santana; Nathalia S Carvalho; Talita S Bezerra; Camila B Oliveira; Samara R B Damasceno; Luciano S Chaves; Ana Lúcia P Freitas; Pedro M G Soares; Marcellus H L P Souza; André Luiz R Barbosa; Jand-Venes R Medeiros
Journal:  Mar Drugs       Date:  2012-12       Impact factor: 5.118

5.  Non-steroidal anti-inflammatory drugs activate NADPH oxidase in adipocytes and raise the H2O2 pool to prevent cAMP-stimulated protein kinase a activation and inhibit lipolysis.

Authors:  Héctor Vázquez-Meza; Martha Zentella de Piña; Juan Pablo Pardo; Héctor Riveros-Rosas; Rafael Villalobos-Molina; Enrique Piña
Journal:  BMC Biochem       Date:  2013-05-30       Impact factor: 4.059

Review 6.  Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?

Authors:  N D Yeomans; L-E Svedberg; J Naesdal
Journal:  Int J Clin Pract       Date:  2006-11       Impact factor: 2.503

7.  Ultrasound-guided Intraarticular Hip Injection for Osteoarthritis Pain in the Emergency Department.

Authors:  Erik S Anderson; Andrew A Herring; Caitlin Bailey; Daniel Mantuani; Arun D Nagdev
Journal:  West J Emerg Med       Date:  2013-09

8.  Superior digestive tract side effects after prolonged treatment with NSAIDs in patients with osteoarthritis.

Authors:  O C Rogoveanu; C T Streba; C C Vere; L Petrescu; R Trăistaru
Journal:  J Med Life       Date:  2015 Oct-Dec

Review 9.  Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Chao Xu; Ke Gu; Yalikun Yasen; Yanjie Hou
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

10.  Indomethacin-induced gastric damage in rats and the protective effect of donkey milk.

Authors:  Ebru Tastekin; Suleyman Ayvaz; Ufuk Usta; Nurettin Aydogdu; Ekrem Cancilar; Fulya Oz Puyan
Journal:  Arch Med Sci       Date:  2016-05-20       Impact factor: 3.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.